Candida Albicans News and Research

RSS

Discovery and characterization of a new antifungal compound

Discovery and characterization of a new antifungal compound

Antimicrobial resistance has prompted scientists to search for novel compounds everywhere. A multinational group of European scientists reports the discovery of solanimycin, a novel antifungal antibiotic.

12 Oct 2022

New imaging technologies to evade immune responses of Candida albicans

New imaging technologies to evade immune responses of Candida albicans

Researchers from the Monash Biomedicine Discovery Institute have demonstrated how the common fungus Candida albicans evades immune responses using newly discovered imaging technologies. The researchers claim that this involves a fungus that can shape-shift in an “alien-like” manner to escape immune cells.

21 Sep 2022

Immune-boosting drugs with antibiotics may reduce the health risks of fungal infections

Immune-boosting drugs with antibiotics may reduce the health risks of fungal infections

Patients are more susceptible to fungal infections because the immune system in the gut is disrupted when patients are given antibiotics in the hospital.

18 May 2022

Researchers discover unusual exploitation of the human immune system by fungus Candida albicans

Researchers discover unusual exploitation of the human immune system by fungus Candida albicans

During infection, the yeast Candida albicans stimulates the release of tiny RNA fragments, which then stimulate its own growth.

3 Mar 2022

Antibodies play a major role in managing gut mycobiota, says study

Antibodies play a major role in managing gut mycobiota, says study

According to recent research, antibody protection against harmful forms of fungi in the gut might be disrupted in some patients with Crohn’s disease.

25 Nov 2021

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.